Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CPD |
| Upstream (Parents) |
|---|
| (<<) ADAM10 → CPD |
| (<<) CRKL → CPD |
| (<<) DHX9 → CPD |
| (<<) DYNLL1 → CPD |
| (<<) GNAQ → CPD |
| (<<) MAPK1 → CPD |
| (<<) MCL1 → CPD |
| (<<) PCSK7 → CPD |
| (<<) PPIF → CPD |
| (<<) RAB5A → CPD |
| (<<) SGSH → CPD |
| (<<) STAM2 → CPD |
| Downstream (Children) |
|---|
| CPD → ATF2 (>>) |
| CPD → ATP2A2 (>>) |
| CPD → ATP2B4 (>>) |
| CPD → CCND3 (>>) |
| CPD → EML4 (>>) |
| CPD → IVL (>>) |
| CPD → LDLR (>>) |
| CPD → MAP3K2 (>>) |
| CPD → PTPN11 (>>) |
